Here are four takeaways:
1. Dr. Stevens, a gastroenterologist, has more than 17 years of senior management and consulting experience in drug development.
2. He has served in numerous leadership roles in drug companies, including serving as senior vice president of clinical development at Alnara Pharmaceuticals.
3. Dr. Stevens also previously worked as a clinical and research gastroenterologist at Beth Israel Deaconess Medical Center and as an assistant professor of medicine at Harvard Medical School, both located in Boston.
4. Arsanis is a clinical-stage company focused on the development of targeted monoclonal antibodies for the treatment of infectious diseases.
More articles on GI/endoscopy:
Exact Sciences, Anthem BCBS to provide Cologuard in 5 states, Intercept Pharmaceuticals’ Ocaliva receives FDA approval — 5 GI company key notes
Olympus launches Olympus Knowledge Exchange system: 3 points
AGA names Dr. Timothy Wang president: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
